Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations?

Affiliations

Comment

Robert C Stanton. Am J Kidney Dis. 2015 Aug.

. 2015 Aug;66(2):193-5.

doi: 10.1053/j.ajkd.2015.04.001. Epub 2015 May 8.

¹ Joslin Diabetes Center, Harvard Medical School, Boston, MA. Electronic address: robert.stanton@joslin.harvard.edu.

No abstract available

Comment in

Restricting Metformin in CKD: Continued Caution Warranted.
Rhee CM, Kalantar-Zadeh K. Rhee CM, et al. Am J Kidney Dis. 2015 Dec;66(6):1101-2. doi: 10.1053/j.ajkd.2015.07.039. Am J Kidney Dis. 2015. PMID: 26593314 Free PMC article. No abstract available.
In Reply to 'Restricting Metformin in CKD: Continued Caution Warranted'.
Stanton RC. Stanton RC. Am J Kidney Dis. 2015 Dec;66(6):1102. doi: 10.1053/j.ajkd.2015.09.012. Am J Kidney Dis. 2015. PMID: 26593315 No abstract available.

Metformin in patients with type 2 diabetes and kidney disease: a systematic review.
Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK. Inzucchi SE, et al. JAMA. 2014 Dec 24-31;312(24):2668-75. doi: 10.1001/jama.2014.15298. JAMA. 2014. PMID: 25536258 Free PMC article.